SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-060918
Filing Date
2021-12-22
Accepted
2021-12-22 08:00:35
Documents
13
Period of Report
2021-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K drrx-8k_20211221.htm   iXBRL 8-K 45697
2 EX-99.1 drrx-ex991_6.htm EX-99.1 34506
  Complete submission text file 0001564590-21-060918.txt   216642

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA drrx-20211221.xsd EX-101.SCH 5677
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20211221_lab.xml EX-101.LAB 18580
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20211221_pre.xml EX-101.PRE 11029
7 EXTRACTED XBRL INSTANCE DOCUMENT drrx-8k_20211221_htm.xml XML 3407
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31615 | Film No.: 211511019
SIC: 2834 Pharmaceutical Preparations